Hirasawa N, Watanabe M, Mue S, Watanabe K, Tsurufuji S, Ohuchi K
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan.
Inflammation. 1992 Apr;16(2):187-96. doi: 10.1007/BF00918958.
In vivo effects of cytokine-induced neutrophil chemotactic factor (CINC) derived from rats on neutrophil infiltration were investigated using an air-pouch-type inflammation model in rats, and effects of dexamethasone on neutrophil infiltration induced by CINC was also examined in order to gain further insight into the mechanism of antiinflammatory activity of glucocorticoids. Injection of CINC into the air pouch made on the dorsum of rats induced a marked infiltration of neutrophils into the pouch fluid but not mononuclear cells and eosinophils during a 30-min interval after the injection. Maximum effect was induced at a dose of 1.4 micrograms/pouch. Treatment with dexamethasone 3 h before the injection of CINC suppressed the neutrophil infiltration in a dose-dependent manner, but no complete inhibition was observed. CINC injection into the air pouch of rats that had been sacrificed by bleeding in order to minimize neutrophil infiltration from blood stream also stimulated neutrophil infiltration into the pouch fluid when the carcass was incubated at 37 degrees C for 30 min, but the number of infiltrated neutrophils was about 35% of CINC-induced neutrophil infiltration in intact rats. CINC-induced neutrophil infiltration in the carcass, which is supposed to be a reflection of neutrophil migration from extravascular space in subcutaneous tissues to pouch fluid, was not inhibited by dexamethasone treatment. Therefore, the inhibition of neutrophil infiltration by dexamethasone might be due to inhibition of the extravasation of peripheral neutrophils but not due to inhibition of neutrophil chemotaxis from subcutaneous extravascular space to pouch fluid. These findings suggest that clinical effects of steroidal antiinflammatory drugs on neutrophil infiltration in inflammatory disease is partly due to inhibition of neutrophil extravasation induced by preformed neutrophil chemotactic factors in the inflammatory site.
利用大鼠气袋型炎症模型研究了大鼠来源的细胞因子诱导的中性粒细胞趋化因子(CINC)对中性粒细胞浸润的体内作用,并且还检测了地塞米松对CINC诱导的中性粒细胞浸润的影响,以便更深入地了解糖皮质激素的抗炎活性机制。向大鼠背部制作的气袋中注射CINC,在注射后的30分钟内,可诱导中性粒细胞显著浸润到袋液中,但单核细胞和嗜酸性粒细胞未浸润。在剂量为1.4微克/袋时可诱导最大效应。在注射CINC前3小时用地塞米松治疗,以剂量依赖的方式抑制了中性粒细胞浸润,但未观察到完全抑制。为了尽量减少来自血流的中性粒细胞浸润,对已通过放血处死的大鼠气袋注射CINC,当尸体在37℃孵育30分钟时,也刺激了中性粒细胞浸润到袋液中,但浸润的中性粒细胞数量约为完整大鼠中CINC诱导的中性粒细胞浸润的35%。CINC诱导的尸体中的中性粒细胞浸润,这被认为反映了中性粒细胞从皮下组织的血管外空间迁移到袋液中,不受地塞米松治疗的抑制。因此,地塞米松对中性粒细胞浸润的抑制可能是由于抑制外周中性粒细胞的渗出,而不是由于抑制中性粒细胞从皮下血管外空间到袋液的趋化作用。这些发现表明,甾体类抗炎药对炎症性疾病中中性粒细胞浸润的临床作用部分是由于抑制了炎症部位预先形成的中性粒细胞趋化因子诱导的中性粒细胞渗出。